GlassScriptPhysician profile
Raymond P Onders
NPI 1033139712
$1,244,972.46
in general payments reported to CMS, 2019-2025
15 companies · $369K in 2025
The $369K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114K · 2020: $123K · 2021: $142K · 2022: $127K · 2023: $182K · 2024: $188K · 2025: $369K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $614K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $123K · Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $614,390.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,165.92 |
| Food and Beverage | $1,444.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synapse Biomedical INC | $1,236,447.25 | 2019-2025 | Neurx Diaphragm Pacing System |
| Covidien LP | $6,327.20 | 2019-2020 | |
| Tela Bio, INC. | $479.41 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $442.18 | 2021-2024 | Arista Ah Flexitip |
| Aroa Biosurgery Incorporated | $388.33 | 2022-2025 | |
| Integra Lifesciences Corporation | $164.53 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $127.41 | 2021 | |
| Baxter Healthcare | $125.53 | 2025 | Floseal |
| Haemonetics Corporation | $124.04 | 2025 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $113.06 | 2022 | |
| Kci USA, INC. | $100.16 | 2023 | V.A.C. Veraflo, Abthera |
| Heron Therapeutics, INC. | $51.26 | 2022 | |
| Ethicon US, LLC | $35.71 | 2021 | |
| Becton, Dickinson and Company | $28.25 | 2023 | Phasix Mesh |
| Medtronic, INC. | $18.14 | 2023 | Signia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,655,234.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Onders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.